{"nct_id":"NCT01596621","title":"A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2012-08-06","start_date_type":"ACTUAL","primary_completion_date":"2015-06-18","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}